{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:22:00Z","timestamp":1777580520721,"version":"3.51.4"},"reference-count":62,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin conditions. In the era of anti-retroviral therapy, we have discovered even more about the relationship between skin disease and chronic immunosuppression. In particular, clinicians still face the propensity of persons living with HIV to develop difficult-to-control viral infections, chronic skin inflammation, and pruritus and\u2014particularly as patients age\u2014various types of skin cancers. Here, we summarize recent updates in the field of HIV dermatology and make recommendations to providers caring for these patients.<\/ns4:p>","DOI":"10.12688\/f1000research.16182.1","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T04:50:08Z","timestamp":1561697408000},"page":"980","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["What\u2019s new in HIV dermatology?"],"prefix":"10.12688","volume":"8","author":[{"given":"Sarah J","family":"Coates","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieron S","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"ref-1","article-title":"Miles to go\u2014closing gaps, breaking barriers, righting injustices","year":"2018"},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"2295-301","DOI":"10.1097\/QAD.0000000000001639","article-title":"Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?","volume":"31","author":"M Siegenbeek van Heukelom","year":"2017","journal-title":"AIDS."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"627-34","DOI":"10.1111\/ijd.13819","article-title":"Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.","volume":"57","author":"L Bacik","year":"2018","journal-title":"Int J Dermatol."},{"key":"ref-4","article-title":"Human Papillomavirus.","year":"2018","journal-title":"Natl. Cent. Immun. Respir. Dis."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"735-44","DOI":"10.1093\/cid\/cit319","article-title":"Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.","volume":"57","author":"J Kahn","year":"2013","journal-title":"Clin Infect Dis."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"1339-46","DOI":"10.1093\/cid\/ciy274","article-title":"A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.","volume":"67","author":"T Wilkin","year":"2018","journal-title":"Clin Infect Dis."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"367-9","DOI":"10.1016\/j.jdcr.2017.05.007","article-title":"Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult.","volume":"3","author":"S Ferguson","year":"2017","journal-title":"JAAD Case Rep."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"e119-e123","DOI":"10.1093\/cid\/cis118","article-title":"Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe.","volume":"54","author":"S Lowe","year":"2012","journal-title":"Clin Infect Dis."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"1344-50","DOI":"10.1111\/ijd.14196","article-title":"A novel approach to the classification of epidermodysplasia verruciformis.","volume":"57","author":"S Huang","year":"2018","journal-title":"Int J Dermatol."},{"key":"ref-10","first-page":"321-324, 330","article-title":"Atypical disseminated herpes zoster: management guidelines in immunocompromised patients.","volume":"100","author":"D Lewis","year":"2017","journal-title":"Cutis."},{"key":"ref-11","article-title":"Shingrix Recommendations.","year":"2018","journal-title":"Natl. Cent. Immun. Respir. Dis."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"459-72","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.","volume":"55","author":"J Piret","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"1553-60","DOI":"10.1016\/j.vaccine.2013.08.066","article-title":"Current status and prospects for development of an HSV vaccine.","volume":"32","author":"C Johnston","year":"2014","journal-title":"Vaccine."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"881-3","DOI":"10.1001\/jamadermatol.2013.4014","article-title":"Intralesional cidofovir for treating extensive genital verrucous herpes simplex virus infection.","volume":"149","author":"K Wanat","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11606-017-4256-y","article-title":"Herpes Vegetans: an Unusual and Acyclovir-Resistant Form of HSV.","volume":"33","author":"S Ronkainen","year":"2018","journal-title":"J Gen Intern Med."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"2495-503","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.","volume":"316","author":"A Wald","year":"2016","journal-title":"JAMA."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"331-40","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: Two randomized controlled trials. Chiron HSV Vaccine Study Group.","volume":"282","author":"L Corey","year":"1999","journal-title":"JAMA."},{"key":"ref-18","first-page":"235-9","article-title":"A double-blind study of the efficacy and safety of the ICP10deltaPK vaccine against recurrent genital HSV-2 infections.","volume":"70","author":"G Casanova","year":"2002","journal-title":"Cutis."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"371-90","DOI":"10.3390\/v6020371","article-title":"HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine.","volume":"6","author":"X Zhu","year":"2014","journal-title":"Viruses."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"6733-45","DOI":"10.1016\/j.vaccine.2014.10.002","article-title":"The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.","volume":"32","author":"T Kuo","year":"2014","journal-title":"Vaccine."},{"key":"ref-21","article-title":"Hopes for a Herpes Virus Vaccine Have Faded.","author":"D Gray","year":"2018","journal-title":"Heal Line."},{"key":"ref-22","article-title":"Syphilis","year":"2016","journal-title":"2016 Sex. Transm. Dis. Surveill."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"2251-2","DOI":"10.1097\/QAD.0000000000001185","article-title":"Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men.","volume":"30","author":"N Kojima","year":"2016","journal-title":"AIDS."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"1527-32","DOI":"10.1097\/QAD.0000000000001874","article-title":"Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project.","volume":"32","author":"E Hoornenborg","year":"2018","journal-title":"AIDS."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"e402-e410","DOI":"10.1016\/S2352-3018(17)30089-9","article-title":"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.","volume":"4","author":"J Molina","year":"2017","journal-title":"Lancet HIV."},{"key":"ref-26","article-title":"Syphilis","year":"2015","journal-title":"2015 Sex. Transm. Dis. Treat. Guidel."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"1389-90","DOI":"10.1001\/jamadermatol.2018.3199","article-title":"Congenital Syphilis-Still a Shadow on the Land.","volume":"154","author":"K Katz","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref-28","article-title":"Statistics","year":"2018"},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"2325957417752255","DOI":"10.1177\/2325957417752255","article-title":"Skin Diseases in the Era of Highly Active Antiretroviral Therapy: A Retrospective Study of 534 Patients.","volume":"17","author":"J Tan","year":"2018","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"e12806","DOI":"10.1111\/dth.12806","article-title":"HIV-associated psoriasis: Epidemiology, pathogenesis, and management.","volume":"32","author":"M Ceccarelli","year":"2019","journal-title":"Dermatol Ther."},{"key":"ref-31","first-page":"38-42, 56","article-title":"Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies.","volume":"101","author":"M Nakamura","year":"2018","journal-title":"Cutis."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"291-9","DOI":"10.1016\/j.jaad.2009.03.047","article-title":"Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.","volume":"62","author":"K Menon","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"714-719.e3","DOI":"10.1016\/j.jaad.2018.04.047","article-title":"Ethnic differences and comorbidities of 909 prurigo nodularis patients.","volume":"79","author":"E Boozalis","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"581-8","DOI":"10.1016\/j.jaad.2005.12.030","article-title":"Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience.","volume":"54","author":"P Zancanaro","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"803752","DOI":"10.1155\/2015\/803752","article-title":"Pruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment Modalities.","volume":"2015","author":"N Tarikci","year":"2015","journal-title":"ScientificWorldJournal."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"1111-8","DOI":"10.1097\/00002030-199709000-00005","article-title":"Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.","volume":"11","author":"S Klein","year":"1997","journal-title":"AIDS."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"1185-8","DOI":"10.1038\/jid.2009.367","article-title":"Epidermal barrier dysfunction in non-atopic HIV: evidence for an \"inside-to-outside\" pathogenesis.","volume":"130","author":"R Gunathilake","year":"2010","journal-title":"J Invest Dermatol."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"446-8","DOI":"10.1111\/exd.12425","article-title":"Similar appearance, different mechanisms: xerosis in HIV, atopic dermatitis and ageing.","volume":"23","author":"M Mischo","year":"2014","journal-title":"Exp Dermatol."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"17325","DOI":"10.7448\/IAS.16.1.17325","article-title":"Etiology and risk factors associated with a pruritic papular eruption in people living with HIV in India.","volume":"16","author":"T Farsani","year":"2013","journal-title":"J Int AIDS Soc."},{"key":"ref-40","article-title":"Skin Cancer","year":"2018"},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"623-7","DOI":"10.1001\/archderm.1992.01680150053003","article-title":"Nonmelanoma skin cancers and infection with the human immunodeficiency virus.","volume":"128","author":"D Lobo","year":"1992","journal-title":"Arch Dermatol."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"350-60","DOI":"10.1093\/jnci\/djs529","article-title":"HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer.","volume":"105","author":"M Silverberg","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"892-6","DOI":"10.1001\/jamadermatol.2017.1716","article-title":"Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.","volume":"153","author":"M Asgari","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"689-95","DOI":"10.1016\/j.jaad.2018.03.024","article-title":"Risk of skin cancer in patients with HIV: A Danish nationwide cohort study.","volume":"79","author":"S Omland","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"2260-5","DOI":"10.1002\/ijc.23391","article-title":"The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004.","volume":"122","author":"L Stein","year":"2008","journal-title":"Int J Cancer."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"683-90","DOI":"10.1001\/jamadermatol.2016.0192","article-title":"Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients.","volume":"152","author":"S Song","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"1745-53","DOI":"10.1038\/jid.2011.91","article-title":"Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma.","volume":"131","author":"S Arron","year":"2011","journal-title":"J Invest Dermatol."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"621-9","DOI":"10.1016\/j.jaad.2014.01.857","article-title":"Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis.","volume":"70","author":"J Wang","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"499-504","DOI":"10.1097\/QAI.0000000000001719","article-title":"Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada.","volume":"78","author":"E Yanik","year":"2018","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/cncr.32158","article-title":"Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base.","volume":"285","author":"A Coghill","year":"2019","journal-title":"Cancer."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"6-11","DOI":"10.1097\/COH.0000000000000327","article-title":"Evolving epidemiology of HIV-associated malignancies.","volume":"12","author":"M Shiels","year":"2017","journal-title":"Curr Opin HIV AIDS."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"866-873","DOI":"10.7326\/M17-2499","article-title":"Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.","volume":"168","author":"M Shiels","year":"2018","journal-title":"Ann Intern Med."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"382-90","DOI":"10.1097\/QAI.0000000000001394","article-title":"Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.","volume":"75","author":"R Dubrow","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"1163-8","DOI":"10.1097\/QAD.0b013e3283031a8a","article-title":"Kaposi's sarcoma in HIV-negative men having sex with men.","volume":"22","author":"F Lanternier","year":"2008","journal-title":"AIDS."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"79-80","DOI":"10.1186\/2047-783x-15-2-79","article-title":"Kaposi sarcoma in a HIV uninfected man who has sex with men.","volume":"15","author":"A Potthoff","year":"2010","journal-title":"Eur J Med Res."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"1267-8","DOI":"10.1111\/bjd.13102","article-title":"Kaposi sarcoma in HIV-negative men who have sex with men.","volume":"171","author":"E Rashidghamat","year":"2014","journal-title":"Br J Dermatol."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"1647-53","DOI":"10.1097\/00002030-200007280-00021","article-title":"Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study.","volume":"14","author":"G Rezza","year":"2000","journal-title":"AIDS."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"355-64","DOI":"10.1111\/hiv.12584","article-title":"The world-wide incidence of Kaposi's sarcoma in the HIV\/AIDS era.","volume":"19","author":"Z Liu","year":"2018","journal-title":"HIV Med."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"505-27","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The Global Burden of Cancer 2013.","volume":"1","author":"Global Burden of Disease Cancer Collaboration","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"433-42","DOI":"10.1016\/j.jaad.2017.12.001","article-title":"Merkel cell carcinoma: An update and review: Pathogenesis, diagnosis, and staging.","volume":"78","author":"K Coggshall","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"497-8","DOI":"10.1016\/S0140-6736(02)07668-7","article-title":"Merkel cell carcinoma and HIV infection.","volume":"359","author":"E Engels","year":"2002","journal-title":"Lancet."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"488-93","DOI":"10.1097\/CCO.0b013e3283495a5b","article-title":"Merkel cell polyomavirus infection and Merkel cell carcinoma in HIV-positive individuals.","volume":"23","author":"U Wieland","year":"2011","journal-title":"Curr Opin Oncol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/8-980\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-980\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-980\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T05:05:19Z","timestamp":1561698319000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/8-980\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":62,"URL":"https:\/\/doi.org\/10.12688\/f1000research.16182.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.17671.r50103","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.17671.r50102","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/8-980\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.17671.r50103, Anisa Mosam, Dermatology Department, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa, 28 Jun 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-980\/v1#referee-response-50103","order":0,"name":"referee-response-50103","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.17671.r50102, Margot Whitfeld, St Vincent's Hospital, University of New South Wales, Sydney, Australia, 28 Jun 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-980\/v1#referee-response-50102","order":1,"name":"referee-response-50102","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}